1.035
Pacific Biosciences Of California Inc Aktie (PACB) Neueste Nachrichten
Potential Upside For Pacific Biosciences of California, Inc. (NASDAQ:PACB) Not Without Risk - simplywall.st
PACB: Piper Sandler Adjusts Price Target for Pacific Biosciences - GuruFocus
PACB: Stephens & Co. Reiterates Overweight Rating | PACB Stock N - GuruFocus
Where Pacific Biosciences Stands With Analysts - Benzinga
PACB Price Target Reduced by Piper Sandler Following Quarterly R - GuruFocus
Metagenomics Market Size, Share, Forecast & Trends Analysis Report 2025: Market to Soar to $6.71 Billion by 2031, Driven by Agri Genomics and Genome Mapping - GlobeNewswire Inc.
PacBio clears allegations after special investigation By Investing.com - Investing.com Canada
PACB Stock May Rise Following the Deal With Chulalongkorn University - Nasdaq
PacBio (PACB) Completes Probe into Employment Practices and Cybe - GuruFocus
PacBio Board Independent Investigation Concludes Allegations Unsubstantiated - Yahoo Finance
Pacbio adjusts 2025 revenue guidance to $150M-$170M amid macroeconomic challenges - MSN
Pacific Biosciences of California First Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
PacBio (PACB) Sees Increased Options Activity Ahead of Earnings - GuruFocus
PacBio Stock Down Despite Q1 Earnings & Revenue Beat Estimates - Yahoo Finance
Pacific Biosciences of California Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2025 Earnings Call Transcript - Insider Monkey
Pacific Biosciences (PACB) Beats Revenue Expectations Amid ChallengesNews and Statistics - IndexBox
Pacific Biosciences of California Q1 2025 Earnings Call Transcript - MarketBeat
Pacific Biosciences: Q1 Earnings Snapshot - Norwalk Hour
PacBio Announces First Quarter 2025 Financial Results - GlobeNewswire
Pacific Biosciences (PACB) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Pacific Biosciences (PACB) Reports Q1 2025 Financials Amid Macroeconomic Challenges - GuruFocus
PacBio (NASDAQ:PACB) Beats Expectations in Strong Q1 - Yahoo Finance
PacBio Q1 2025 slides: Consumable growth offsets instrument revenue decline - Investing.com Canada
Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
PacBio Reports Q1 2025 Financial Results, Announces Restructuring and Strategic Focus Shift - Nasdaq
PacBio (PACB) Sees Increased Options Activity Ahead of Earnings | PACB Stock News - GuruFocus
Pacific Biosciences (PACB) Prepares for Q1 Earnings Announcement - GuruFocus
Earnings To Watch: Pacific Biosciences of California Inc (PACB) Reports Q1 2025 Result - GuruFocus
PacBio (PACB) Q1 Earnings: What To Expect - Yahoo Finance
Pacific Biosciences of California Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
PacBio (PACB) Launches Pioneering Genomic Project in Asia Pacific | PACB Stock News - GuruFocus
First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand - Yahoo Finance
Press Release Distribution & PR Platform - ACCESS Newswire
PacBio (PACB) Q4 Earnings Report Preview: What To Look For - Barchart.com
Pacific Biosciences of California (PACB) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Pacific Biosciences Says New Technology to Enhance HiFi Sequencing - marketscreener.com
PacBio Licenses CUHK AI Tech To Boost 5-Base Methylation Detection In HiFi Sequencing - Nasdaq
PacBio (PACB) Enhances Methylation Detection in HiFi Sequencing - GuruFocus
PacBio Licenses Advanced DNA Methylation Detection Technology to Enhance HiFi Sequencing Accuracy - Nasdaq
PACB stock touches 52-week low at $1.08 amid market challenges - Investing.com Australia
Pacific Biosciences of California (PACB) Flat As Market Gains: What You Should Know - Yahoo Finance
Pacific Biosciences of California Selected by Davos Alzheimer's Collaborative as Technology Partner - marketscreener.com
PacBio partners with global Alzheimer’s initiative By Investing.com - Investing.com India
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):